Liste d'obligations internationales ( Toutes )
| Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
| Celgen Corporation | US151020AU84 | USD | 5% | 2 000 USD | 14/08/2045 | 87.6 | |
| Celgen Corporation | US151020BB94 | USD | 3.9% | 2 000 USD | 19/02/2028 | 100 | |
| Celgen Corporation | US151020AS39 | USD | 3.875% | 2 000 USD | 14/08/2025 | Echue | |
| Celgen Corporation | US151020AQ72 | USD | 2.875% | 2 000 USD | 14/08/2020 | Echue | |
Celgene Corporation was a biopharmaceutical company acquired by Bristol Myers Squibb in 2019, known for its development and commercialization of cancer therapies and other immunology treatments.
Celgene Corporation était une société biopharmaceutique américaine, acquise par Bristol Myers Squibb en 2019, connue pour ses traitements contre le cancer et les maladies inflammatoires.
Celgene Corporation era un'azienda biofarmaceutica statunitense focalizzata sullo sviluppo e la commercializzazione di terapie innovative per il trattamento di malattie oncologiche ed emopatie.